Answers are grounded in this paper and cite their sources.
Review examines barriers to effective kidney recellularization for transplantation, suggesting challenges in current methods.
While there is no cure for end stage renal disease, kidney transplantation is the most effective long-term treatment. However, it comes with significant morbidity related to organ rejection. As of 2024, the wait time for a deceased donor kidney in Ontario is between 2 and 6 years depending on blood type and risk group (1). One of the factors for extensive wait times is the need to find donors who have kidneys that match recipients to reduce risk and intensity of immunosuppression needed. Recent developments in tissue engineering have allowed for kidneys and other whole organs to be decellularized and subsequently recellularized with recipient cells, decreasing the likelihood of rejection. But, at this point no human has ever received a recellularized kidney (2). This work investigates barriers that current and emerging methods are encountering when trying to achieve whole kidney recellularization for transplantation.
No takes yet. Share an insight, caveat, or question.
Ezra Sussman (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: